Company Panacea Global Inc OTC Bulletin Board
Equities
US6981031080
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yuri Lawryshyn
CEO | Chief Executive Officer | 58 | 16-06-16 |
David Sohi
DFI | Director of Finance/CFO | - | 16-06-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yuri Lawryshyn
CEO | Chief Executive Officer | 58 | 16-06-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 106,747,586 | 24,747,586 ( 23.18 %) | 0 | 23.18 % |
Company contact information
Panacea Global, Inc.
330 Highway 7 East Suite 502
L4B 3P8, Richmond Hill
+
Sector
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- PANG Stock
- Stock
- Company Panacea Global Inc